These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3809929)

  • 1. [Preclinical study of anti-arrhythmia agents. Classification].
    Dupuis B; Caron J
    Rev Prat; 1986 Nov; 36(53):3109-14. PubMed ID: 3809929
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-arrhythmia agents: results and outlook].
    Kaverina NV
    Eksp Klin Farmakol; 1994; 57(6):12-5. PubMed ID: 7756947
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessment of antiarrhythmic drugs in experimental pharmacology.
    Caillard CG; Louis JC
    Methods Find Exp Clin Pharmacol; 1980 Oct; 2(5):223-52. PubMed ID: 6765586
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental evaluation of antiarrhythmic drugs efficacy.
    Schwartz PJ; Vanoli E; Zaza A; Zuanetti G
    Cardiologia; 1983 Sep; 28(9):747-65. PubMed ID: 6687331
    [No Abstract]   [Full Text] [Related]  

  • 5. [A model of tachyarrhythmia in awake animals].
    Iakushev MP
    Biull Eksp Biol Med; 1997 Aug; 124(8):237-40. PubMed ID: 9410220
    [No Abstract]   [Full Text] [Related]  

  • 6. [The anti-arrhythmia effect of Rhodiola rosea and its possible mechanism].
    Lishmanov IuB; Maslova LV; Maslov LN; Dan'shina EN
    Biull Eksp Biol Med; 1993 Aug; 116(8):175-6. PubMed ID: 7506072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacology and classification of anti-arrhythmia agents].
    Giudicelli JF; Lhoste F
    Rev Prat; 1975 Oct; 25(45):3449-52, 3455-8. PubMed ID: 1209115
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antifibrillatory activity of anti-arrhythmia agents in maximally high ligation of the coronary artery and its reperfusion in cats].
    Storozhuk BG
    Farmakol Toksikol; 1985; 48(3):47-9. PubMed ID: 4029380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening for anti-arrhythmic activity in mice].
    Foussard-Blanpin O; Sevestre V
    J Pharmacol; 1980; 11(4):473-4. PubMed ID: 7206735
    [No Abstract]   [Full Text] [Related]  

  • 10. [Present classification of anti-arrhythmia agents].
    Hashimoto K
    Nihon Rinsho; 1985 Nov; 43(11):2243-7. PubMed ID: 4087403
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sodium channels and anti-arrhythmia agents. Time for a new classification?].
    Elinder F; Arhem P
    Lakartidningen; 1993 Dec; 90(50):4545-9. PubMed ID: 8264290
    [No Abstract]   [Full Text] [Related]  

  • 12. [The anti-arrhythmia activity of new dicyclohexylamide derivatives of N-substituted alpha-aminocarboxylic acids].
    Berdiaev SU; Paliani-Katsitadze NSh; Turilova AI; Kaverina NV; Likhosherstov AM; Lebedeva AS; Ogurtsov VA
    Eksp Klin Farmakol; 1999; 62(4):26-9. PubMed ID: 10513331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology and classification of antiarrhythmic drugs.
    MacFadyen RJ; Prasad N
    Br J Hosp Med; 1995 Nov 15-Dec 12; 54(10):515-9. PubMed ID: 8574495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
    Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
    Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands].
    Lishmanov IuB; Maslov LN; Krylatov AV; Ugdyzhekova DS; Gilligan P; Tam SW
    Eksp Klin Farmakol; 2000; 63(2):39-43. PubMed ID: 10834092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The anti-arrhythmia activity of energy-providing and electron-acceptor compounds].
    Balashov VP; Balykova LA; Kostin IaV; Sernov LN
    Eksp Klin Farmakol; 1996; 59(2):17-9. PubMed ID: 8974556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Classification of antiarrhythmic agents and their therapeutic impact].
    Senges J; Hennig E
    Med Klin Prax; 1982 Apr; 77(9):28-35. PubMed ID: 6123938
    [No Abstract]   [Full Text] [Related]  

  • 18. [The anti-arrhythmia properties of thymogen].
    Reznikov KM; Vinokurova OV; Alabovskiĭ VV; Vinokurov AA
    Eksp Klin Farmakol; 1994; 57(6):31-3. PubMed ID: 7756955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias].
    Maĭmeskulova LA; Maslov LN
    Eksp Klin Farmakol; 1998; 61(2):37-40. PubMed ID: 9621172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-arrhythmia agents: classification, mode of action, and therapeutic usefulness].
    Tamargo J; Delpón E; Valenzuela C; Pérez O
    Rev Clin Esp; 1993 Mar; 192(4):189-96. PubMed ID: 8386844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.